Search for: "Eli Lilly " Results 1501 - 1520 of 2,131
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
26 Feb 2010, 12:59 pm by Andrew A. Lundgren
Eli Lilly & Co. and that the Federal Circuit's forthcoming decision in that case may alter the scope and purpose of the written description requirement. [read post]
24 Feb 2010, 11:20 am by mcarzima@imediainc.com
Click here to read the full article, “Ark. announces $18.5M settlement with Eli Lilly" [read post]
24 Feb 2010, 2:11 am
(IP Watch) Exploring a new angle in the TRIPS and drug patents debate (Spicy IP) EPO Enlarged Board of Appeal rules on patenting a method of treatment by surgery: G1/07 (IPKat) (EPLAW) (Patent Baristas) EPO Enlarged Board of Appeal decides on dosage regime – Swiss-type claims no longer available: G 2/08 – Dosage Regime/Abbot Respiratory (EPLAW) (Managing Intellectual Property) (IPKat) (Patent Baristas) India: Victory for access to medicines as Bayer loses lawsuit in India (GenericsWeb)… [read post]
24 Feb 2010, 2:11 am
(IP Watch) Exploring a new angle in the TRIPS and drug patents debate (Spicy IP) EPO Enlarged Board of Appeal rules on patenting a method of treatment by surgery: G1/07 (IPKat) (EPLAW) (Patent Baristas) EPO Enlarged Board of Appeal decides on dosage regime – Swiss-type claims no longer available: G 2/08 – Dosage Regime/Abbot Respiratory (EPLAW) (Managing Intellectual Property) (IPKat) (Patent Baristas) India: Victory for access to medicines as Bayer loses lawsuit in India (GenericsWeb)… [read post]
18 Feb 2010, 10:34 am by Beck, et al.
This post is about un-preempted fraud on the FDA claims and how to approach them…. [read post]
18 Feb 2010, 7:39 am by Dennis Crouch
: A Comprehensive Assessment of the Impact of Eli Lilly and its Progeny in the Courts and PTO , 17 ALB. [read post]
17 Feb 2010, 2:43 pm
This case concerns an appeal [2010] EWCA Civ. 33 from the August 2008 judgment in Eli Lilly & Co. v Human Genome Sciences Inc., [2008] EWHC 1903 (Pat), wherein Mr. [read post]
17 Feb 2010, 2:43 pm
This case concerns an appeal [2010] EWCA Civ. 33 from the August 2008 judgment in Eli Lilly & Co. v Human Genome Sciences Inc., [2008] EWHC 1903 (Pat), wherein Mr. [read post]
17 Feb 2010, 4:54 am by Broc Romanek
- MDU Resources Group - Covidien Public Limited Company - Eli Lilly Thanks to Ken Wagner of Peabody Energy Corp. and Matt Tolland of Wilson Sonsini for pointing some of these new ones out! [read post]
15 Feb 2010, 8:49 am by Dennis Crouch
Eli Lilly: This en banc case is fully briefed and pending decision on the question of whether the written description requirement of Section 112 should be considered separate and distinct from the enablement requirement. [read post]
11 Feb 2010, 4:37 am by Broc Romanek
Here are a few samples we found so far - the first four have been truly filed under the new rules; the last three have not but have some attributes that address some of the new requirements: - Fortune Brands (preliminary proxy filed under new rules) - Eli Lilly (preliminary proxy filed under new rules) - Analog Devices (filed early under new rules) - Hovanian Enterprises (another early adopter) - Point Blank Solutions (director qualification language from proxy contest two… [read post]
10 Feb 2010, 4:47 pm
- UK: EWCA dismisses Human Genome Sciences appeal against decision finding invalidity; invention not ‘susceptible of industrial application’: Eli Lilly v Human Genome Sciences Inc (EPLAW) (IPKat) Nuvigil (Armodafinil) – US: Patent infringement complaints filed in Colorado and Delaware following a Paragraph IV certification as part of Sandoz's filing of an ANDA to manufacture a generic version of Cephalon's Nuvigil: Cephalon, Inc. et al. v. [read post]
10 Feb 2010, 11:56 am by Beck, et al.
Eli Lilly & Co., 485 N.E.2d 551, 553 (Ill. [read post]
10 Feb 2010, 7:49 am by Sonya Hubbard
  An example is the preliminary proxy that pharmaceutical giant Eli Lilly and Company (LLY) filed on Monday. [read post]
9 Feb 2010, 11:58 pm
In August 2008 Mr Justice Kitchin delivered a mega-judgment in Eli Lilly & Co v Human Genome Sciences Inc, [2008] EWHC 1903 (Pat) on patent validity (noted by the IPKat here). [read post]